The Omaha-based carrier plans to offer Medicare Advantage plans with a prescription drug benefit in selected markets.
Mutual of Omaha announces a strategic alliance with Lumeris, a company with over 10 years of experience with Medicare Advantage plans using a successful, collaborative payer model to deliver better clinical outcomes for patients.
Mutual Chairman and CEO James Blackledge said the alliance will further solidify Mutual of Omaha’s leadership in the senior health market:
Mutual of Omaha was one of the first providers of Medicare Supplement plans, and we intend to continue to meet the changing health care-related needs of seniors. By entering the Medicare Advantage market with Lumeris’ proven value-based care model, we will be able to offer our senior customers a full array of solutions.
Mutual of Omaha will own and carry the name of the new Medicare Advantage plans and provide brand, marketing and distribution expertise and capital. Lumeris will work as a strategic operating partner to help evaluate markets, establish networks, align with providers and administer plans. An Executive Steering Committee comprised of Mutual and Lumeris representatives will provide oversight and governance of the plans. In addition, Blackledge has joined the Lumeris board of directors.
Lumeris Chairman and CEO Mike Long said:
Our new initiative with Mutual of Omaha is exciting because it enables both of our companies to build on our successes, while remaining laser-focused on what matters most—delivering the highest quality care to seniors. This new partnership also leverages each company’s unique strengths to benefit the larger health care ecosystem. Together, we will make a deeper, more meaningful difference in the lives of patients and providers.
Learn more from the Mutual of Omaha news release.